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ABSTRACT
The reaction of potassium salts of RNHCSSK with 2-chloro-1-(3-methyl-3-phenylcyclobutyl)ethan-1-one in ethanol at 78–80°C
afforded new 1,3-thiazole-2(3H)-thiones containing 1,1,3-trisubstituted cyclobutane rings at C-4. The antimicrobial activities of
these compounds were also investigated against seven different microorganisms, and some of them were found to be active
against several of the microorganisms at higher concentrations.
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1. Introduction
-Haloketones are frequently used in the synthesis of thiazole,
oxazole and thiazolidine-2-thiones or 1,3-thiazole-2(3H)-
thiones. 1,3-Thiazole-2(3H)-thiones have found many uses in
recent years in such diverse fields as photography, agro-
chemistry and radiochemistry.1–12 In agrochemistry in particular,
different derivatives of 1,3-thiazole-2(3H)-thiones are used as
potential plant protecting compounds, e.g. as fungicides, herbi-
cides, nematicides and insecticides.13 It is well known that 3-sub-
stituted cyclobutanecarboxylic acid derivatives exhibit anti-in-
flammatory and antidepressant activities.14 Cukurovali et al.
have reported the synthesis and characterization of
cyclobutane-substituted thiazolecarbamate ligands. They used
these ligands to complex with some first-row transition metals,
and investigated their antimicrobial activities.15 It has been
reported that several thiazoles and thiazolidin-4-ones are of
biological importance especially as antimetabolites and
schistosomicides.16
In the present paper, we report the synthesis, characterization
and antibacterial activity of new 4-(3-methyl-3-phenyl-
cyclobut-1-yl)-1,3-thiazole-2(3H)-thiones. It is possible that com-
pounds bearing both cyclobutane and 4-thiazoline-2-thione
moieties may display very interesting bioactivities. However,
the synthesis and physicochemical properties of 4-(3-methyl-3-
phenylcyclobut-1-yl)-1,3-thiazole-2(3H)-thiones have not been
reported so far. These compounds containing cyclobutane and
1,3-thiazole-2(3H)-thione units seem to be suitable candidates
for further chemical modifications and may be pharmacologi-
cally active as well as useful ligands in coordination chemistry.
2. Results and Discussion
Treatment of potassium salts RNH(C=S)SK 1 (R = benzyl,
phenyl, anilino, cyclohexyl, n-butyl and piperidin-1-yl) in etha-
nol with 2-chloro-1-(3-methyl-3-phenylcyclobutyl)ethanone 2
at 25–30°C afforded 4-hydroxy-1,3-thiazolidine-2-thiones 3.17,18
Increasing the temperature from 25–30°C to 80°C in the reaction
between 1 and 2 resulted in the elimination of water to give the
expected 4-substituted 1,3-thiazole-2(3H)-thiones 4–9
(Scheme 1). The mechanism of formation for compounds 4–9 is
proposed to be as shown in Scheme 1.
The cyclic structures 4–9 were characterized by means of IR, 1H
and 13C NMR spectroscopy as well as by elemental analysis.
Melting points for all these compounds were determined by
conventional methods and checked by the DSC technique, but
are uncorrected.
Since the substituent in the thiazole-2-thione ring at C-4
(3-phenyl-3-methycyclobut-1-yl) is the same in all the com-
pounds, similar IR characteristics were observed for this compo-
nent of the products. The absence of OH absorption bands and
the presence of the [NC(=S)S-] absorption band in the IR
spectrum for 4–9 indicate the formation of the expected
compounds. The series of products 4–9 shows absorption bands
(KBr; cm–1) at 1586, 1585, 1586, 1570, 1575, 1576, respectively,
which are characteristic for the [NC(=S)S-] function of the
1,3-thiazole-2(3H)-thione ring. Additionally, in the IR spectra of
compound 6, there is a band at 3313 cm–1 which is characteristic
for the N–H stretching of the N-anilino substituent.
The 1H NMR spectra of compounds 4–9 showed the methine
proton (>C-H in the cyclobutane ring) at  3.30, 3.18, 3.25, 3.51,
3.55 and 3.57, respectively; methylene protons (CH2 in the
cyclobutane ring) at  2.33 2.38, 2.00-2.39, 2.00-2.44, 2.15 2.59,
2.40 2.62 and 2.17 2.58, respectively; and methyl protons (CH3) at
 1.44, 1.32, 1.38, 1.32, 1.59, and 1.58, respectively. These chemical
shifts are characteristic for cyclobutane rings.18 The 1,3-thiazole-
2(3H)-thione protons (=CH-S) appear as singlets at  6.20, 6.27,
6.52, 6.14, 6.17 and 6.01, respectively for 4–9. As expected, aro-
matic protons appear as multiplets in the range  6.26–7.65. The
D2O exchangeable NH proton of the compound 6 is a broad
singlet at  7.88. The 13C NMR spectral data of the compounds,
the numbering system for which is shown in Scheme 2, corrobo-
rated the 1H NMR spectral results. Additional signals were
observed in the 13C NMR spectrum of compound 7, for which
two conformations of the cyclohexane ring (i.e., with the
substituent either axial or equatorial) are possible. Detailed 1H
NMR and 13C NMR data for the compounds are given in the
experimental section.
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3. Antimicrobial Results
For the biological evaluation of the compounds synthesized in
this work, screening against seven different microorganisms
was carried out. The test results obtained are listed in Table 1.
Antimicrobial data for the drugs amikacin (AMK), ampicillin
(AMP), chloramphenicol (CHL) and penicillin G (PEN) are also
included in this Table for purposes of comparison.
There was no significant effect of compounds 4, 8 and control
(DMSO) on the growth of the microorganisms used in the
screen. The inhibition zone was significantly increased on
culture with antibiotic disks dosed with compounds 5, 6, 7 and 9,
the observed effects depending on disk concentration and the
specific microorganism used (Table 1). Compound 6 in particular
was found to be very effective on all the microorganisms tested,
except for P. aeruginosa. As can clearly be seen from Table 1,
compound 6 has the greatest antimicrobial efficiency, followed
by compound 9. E. coli was found to be the most resistant to
the compounds in the study, while the fungus C. albicans was
resistant to the antibiotic drugs penicillin G, ampicillin, chlor-
amphenicol and amikacin. These results indicate the efficacy of
compounds 5, 6, 7 and 9 in the biological systems.
4. Experimental
2-Chloro-1-(3-methyl-3-phenylcyclobutyl)ethan-1-one 2 was
synthesized by well-established methods described in the litera-
ture.19,20 All other starting materials were obtained from commer-
cial suppliers and used without purification. IR spectra
(KBr, cm–1) were recorded on a Mattson 1000 FT-IR spectrometer.
The 1H- and 13C-NMR spectra were recorded on a Varian Gemini
200-MHz spectrometer in DMSO-d6. Chemical shifts values ()
are reported in parts per million (ppm) relative to TMS, and
coupling constants (J) are in Hertz (Hz). The elemental analyses
were performed in the TUBITAK (Centre of Science and
Technology, Research Council of Turkey) laboratory. Thin-layer
chromatography (TLC) analyses were performed on silica gel
plates (PolyGram SILG/UV 254). Melting points were deter-
mined on a Thomas Hovver melting point apparatus and are
uncorrected, but checked by differential scanning calorimetry
(DSC). The microorganism strains used were provided from the
Culture Collection of the Biotechnology Laboratory, Department
of Biology, Faculty of Arts and Sciences, Firat University, Elazig,
Turkey. In addition, standard antibiotic discs were obtained
from Sigma Chemical Co. (St. Louis, USA).
Potassium benzylcarbamodithioate. Representative procedure
Potassium hydroxide (2.80 g, 0.05 mol) was added in portions
to a stirred solution of benzylamine (5.35 g, 0.05 mol) in diethyl
ether (20 ml) at 0°C. After stirring for 30 min, carbon disulphide
(4.6 g, 0.06 mol) was added dropwise at 0–10°C over 1 h. The
reaction mixture was stirred at 25–30°C for 24 h. The solid thus
formed was collected by filtration, washed with diethyl ether
(50 ml) and dried in air at 25–30°C. Potassium benzylcarba-
modithioate, [C6H5CH2NHC(=S)SK], was obtained in 93% yield
and was used without further purification.
3-Benzyl-4-(3-methyl-3-phenylcyclobut-1-yl)-1,3-thiazole-2(3H)-
thione 4. General procedure
2-Chloro-1-(3-methyl-3-phenylcyclobutyl)ethan-1-one 2
(4.45 g, 0.02 mol) was added in portions to a stirred slurry
containing the above potassium salt (4.4 g, 0.02 mol) in ethanol
(40 ml). After stirring for 50 min the temperature had risen from
20 to 40°C. The stirred reaction mixture was heated at reflux
(78–80°C) for 4 h and then allowed to cool. Stirring was main-
tained at 25–30°C for 24 h. After cooling to 5°C, water (60 ml) was
added. The solid was collected by filtration, washed with water
and dried in air at 25–30°C. After recrystallization from ethanol
(32%), 3-benzyl-4-(3-methyl-3-phenylcyclobut-1-yl)-1,3-thiazole-
2(3H)-thione 4 melted at 151–152°C. IR (KBr, cm–1) 1363 and 1302
[NC(=S)S mode of 1,3-thiazole-2(3H)-thione ring] and 1577
[mode of 1,3-thiazole-2(3H)-thione ring],17,18 1024 (C=S). 1H
NMR (200 MHz, DMSO-d6, ppm):  1.44 (s, 3H, CH3), 2.33 2.38 (m,
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Scheme 1
Suggested reaction path for the formation of 4-substituted thiazole-2(3H)-thiones 4–9.
Scheme 2
The numbering system of the compounds for 13C NMR spectra.
4H, CH2), 3.30 (quint, 1H, J 9 Hz, CH of cyclobutane), 5.52 (s, 2H,
CH2C6H5), 6.20 (s, 1H, =CH of thiazolethione ring), 7.04–7.43 (m,
10H, aromatics). 13C NMR (50.34 MHz, DMSO-d6, ppm):  191.82
(C1), 107.13 (C2), 149.94 (C3), 31.87 (C4), 40.97 (C5), 41.44 (C6), 30.40
(C7), 152.87 (C8), 126.41 (C9), 130.95 (C10), 128.34 (C11), 55.13 (C12),
137.11 (C13), 129.87 (C14), 130.44 (C15), 127.82 (C16). Anal. Calcd. for
C21H21NS2: C, 71.79; H, 5.98; N, 3.99; S, 18.23. Found: C, 72.10; H,
6.08; N, 4.22; S, 18.39%.
The following compounds were prepared in similar fashion:
3-Phenyl-4-(3-methyl-3-phenylcyclobut-1-yl)-1,3-thiazole-2(3H)-
thione 5: white crystals (50%), m.p. 179–180°C. IR (KBr, cm–1) 1338
and 1298 [NC(=S)S mode of 1,3-thiazole-2(3H)-thione ring] and
1574 [mode of 1,3-thiazole-2(3H)-thione ring],17,18 1064 (C=S). 1H
NMR (200 MHz, DMSO-d6, ppm):  1.32 (3H, CH3), 2.00 2.39 (m,
4H, CH2), 3.18 (quint, 1H, J 9 Hz, CH of cyclobutane), 6.26 (s, 1H,
=CH of thiazolethione ring), 6.26 7.65 (m, 10H, aromatics). 13C
NMR (50.34 MHz, DMSO-d6, ppm):  192.64 (C1), 107.22 (C2),
139.88 (C3), 31.84 (C4), 41.04 (C5), 41.50 (C6), 30.96 (C7), 150.30 (C8),
130.40 (C9), 131.72 (C10), 130.40 (C11), 153.05 (C12), 126.40 (C13),
131.79 (C14), 127.74 (C15). Anal. Calcd. for C20H19NS2: C, 71.23; H,
5.64; N, 4.15; S, 18.99. Found: C, 71.55; H, 5.73; N, 4.40; S, 19.39%.
3-Anilino-4-(3-methyl-3-phenylcyclobut-1-yl)-1,3-thiazole-2(3H)-
thione 6: white crystals (60%), m.p. 145–146°C. IR (KBr, cm–1) 1346
and 1303 (NC(=S)S- mode of 1,3-thiazole-2(3H)-thione ring) ,
and 1602 (mode of 1,3-thiazole-2(3H)-thione ring)17,18, 1029
(C=S), 3313 (NH). 1H NMR (200 MHz, DMSO-d6, ppm):  1.38 (s,
3H, CH3), 2.00–2.44 (m, 4H, CH2), 3.25 (quint, 1H, J 9, CH of
cyclobutane), 6.52 (s, 1H, =CH of thiazolethione ring), 6.90–7.39
(m, 10H, aromatics), 7.34 (s, 1H, NH). 13C NMR (50.34 MHz,
DMSO-d6, ppm):  191.82 (C1), 107.13 (C2), 149.94 (C3), 36.74 (C4),
37.22 (C5), 40.58 (C6), 32.43 (C7), 147.79 (C8),), 126.52 (C9), 130.38
(C10), 127.66 (C11), 153.24 (C12), 117.10 (C13), 131.18 (C14), 124.58
(C15). Anal. Calcd. for C20H20N2S2: C, 68.18; H, 5.68; N, 7.95; S,
18.18. Found: C, 68.35; H, 5.77; N, 8.15; S, 18.51%.
3-Cyclohexyl-4-(3-methyl-3-phenylcyclobut-1-yl)-1,3-thiazole-2
(3H)-thione 7: white crystals (50%), m.p. 179–180°C. IR (KBr, cm–1)
1344 and 1284 [NC(=S)S- mode of 1,3-thiazole-2(3H)-thione
ring] , and 1573 [mode of 1,3-thiazole-2(3H)-thione ring],17,18 1079
(C=S). 1H NMR (200 MHz, DMSO-d6, ppm):  1.19–1.25 (m, 5H,
CH2 of cyclohexane), 1.32 (s, 3H, CH3), 1.43–1.95 (m, 5H, CH2 of
cyclohexane), 2.15–2.59 (m, 4H, CH2 of cyclobutane), 3.51 (quint,
1H, J 9, CH of cyclobutane), 3.87 (m, 1H, NCH of cyclohexane),
6.14 (s, 1H, =CH of thiazolethione ring), 7.12–7.35 (m, 5H,
aromatics). 13C NMR (50.34 MHz, DMSO-d6, ppm):  190.65 (C1),
108.77 (C2), 150.59 (C3), 32.18 (C4), 401.18 (C5), 41.53 (C6), 28.94 (C7),
152.92 (C8),), 126.49 (C9), 130.47 (C10), 127.84 (C11), 63.81 (C12), 30.88
(C13), 28.60 (C14), 26.00 (C15), 127.82 (C16). Anal. Calcd. for
C20H24NS2: C, 70.17; H, 7.02; N, 4.09; S, 18.71. Found: C, 70.52; H,
7.12; N, 4.34; S, 19.03%.
3-Butyl-4-(3-methyl-3-phenylcyclobut-1-yl)-1,3-thiazole-2(3H)-
thione 8: white crystals (53%), m.p. 93–94°C. IR (KBr, cm–1): 1352
and 1278 [NC(=S)S- mode of 1,3-thiazole-2(3H)-thione ring] and
1576 [mode of 1,3-thiazole-2(3H)-thione ring],17,18 1134 (C=S). 1H
NMR (200 MHz, DMSO-d6, ppm):  1.02 (t, 3H, CH3CH2),
1.41–1.84 (m, 4H, CH2), 1.59 (s, 3H, CH3), 2.40–2.62 (m, 4H, CH2 of
cyclobutane), 3.55 (quint, CH of cyclobutane), 4.10 (t, 2H, NCH2),
6.17 (s, =CH of thiazolethione ring), 7.12–7.37 (m, 5H, aromatics).
13C NMR (50.34 MHz, DMSO-d6, ppm):  190.24 (C1), 107.33 (C2),
149.49 (C3), 32.11 (C4), 41.16 (C5), 41.64 (C6), 30.38 (C7), 152.90 (C8),),
126.46 (C9), 130.49 (C10), 127.86 (C11), 49.38 (C12), 31.56 (C13), 2224
(C14), 15.76 (C15). Anal. Calcd. for C18H23NS2: C, 68.14; H, 7.25; N,
4.42; S, 20.19. Found: C, 68.42; H, 7.37; N, 4.54; S, 20.44%.
4-(3-Methyl-3-phenylcyclobut-1-yl)-3-(piperidin-1-yl)-1,3-thiazole
-2(3H)-thione 9: white crystals (35%), m.p. 175–176°C. IR
(KBr, cm–1): 1355 and 1281 [NC(=S)S- mode of 1,3-thiazole-
2(3H)-thione ring] and 1578 [mode of 1,3-thiazole-2(3H)-thione
ring],17,18 1011 (C=S). 1H NMR (200 MHz, DMSO-d6, ppm):  1.53
(s, 3H, CH3CH2-, 1.63–1.83 (m, CH2), 2.17–2.58 (m, 4H, CH2 of
cyclobutane), 2.89–2.95 (m, CH2), 3.58 (quint, 1H, CH of
cyclobutane), 4.63 (t, 2H, CH2N), 6.01 (s, 1H, =CH of
thiazolethione ring), 7.12–7.36 (m, 5H, aromatics). 13C NMR
(50.34 MHz, DMSO-d6, ppm):  189.27 (C1), 105.29 (C2), 151.58
(C3), 32.21 (C4), 41.29 (C5), 41.44 (C6), 28.66 (C7), 153.41 (C8),), 126.55
(C9), 130.38 (C10), 127.66 (C11), 52.14 (C12), 30.58 (C13), 25.13 (C14).
Anal. Calcd. for C19H24NS2: C, 69.09; H, 7.29; N, 4.24; S, 19.39.
Found: C, 69.45; H, 7.35; N, 4.40; S, 19.62%.
Preparation of microbial cultures
The antimicrobial activities of the compounds 4–9 were tested
against E. coli DH5, Klebsiella pneumonia FMC 5, Staphylococcus
aureus COWAN 1, Streptococcus, Bacillus cereus FMC 39, Pseudomo-
nas aeruginosa DSM 50071 and Candida albicans CCM 314 using
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Table 1 Antimicrobial effects of compounds 4–9. a
Microorganisms/inhibition zones (mm)
Compound Concent. µg/disk E. coli K. pneumoniae S. aureus Streptococcus B. cereus P. aeruginosa C. albicans
4 200 – – – – – – –
400 – – – – – – –
5 200 – – 14 14 14 – 14
400 – 17 17 16 17 15 16
6 200 15 16 17 15 15 14 16
400 18 21 24 19 21 17 23
7 200 – – 14 14 14 15 –
400 16 19 17 17 18 18 16
8 200 – – – – 14 – –
400 – – – – 15 – –
9 200 14 – 16 14 14 15 –
400 16 18 20 17 16 19 16
AMK 27 28 32 26 24 32 –
AMP 20 24 33 23 – 14 –
CHL 28 15 30 25 17 – –
PEN 15 16 33 22 14 14 –
DMSO – – – – – – –
a AMK = amikacin; AMP = ampicillin; CHL = chloramphenicol; PEN = penicillin G, DMSO = dimethyl sulphoxide (control). Inactive (–); moderately active (14–17);
highly active (>17).
DMSO as the solvent at 37°C. The sample concentrations were
200 µg and 400 µg. Standard antibiotic discs containing penicillin
G, ampicillin, chloramphenicol and amikacin purchased from
Sigma Chemical Co. (St. Louis, USA) were used for comparison.
The strain of E. coli used was purchased from Bethesda Research
Laboratories (Gibco-BRL, Paisley, UK). All other microorganism
strains were obtained from the Culture Collection of the Biotech-
nology Laboratory of Firat University, Elazig, Turkey. The YEPD
medium used [1% (w/v) yeast extract, 2% (w/v) bactopeptone
and 2% (w/v) glucose] was from Difco. Cell cultures were
prepared as described by Connerton.21 YEPD medium (5 ml) was
inoculated with each cell from the plate cultures. Cells were
incubated overnight with shaking. These overnight stationary
phase cultures (1 ml) were inoculated into YEPD (200 ml) and
incubated at 30°C with shaking until the OD600 reached 0.5. The
antibiotic sensitivities of the compounds 4–9 were tested by
using the antibiotic disk assay as described by Chan et al.22
Mueller-Hinton Agar [0.5% (w/v) beef extract, 1.75% (w/v)
bactopeptone, 0.5% (w/v) glucose, 1.7% (w/v) agar] was
purchased from Difco. Each cell culture (1 ml) was transferred
into Muller Hinton Agar (MHA) (15 ml) and mixed gently. The
mixture was inoculated into the sterile plate. The plates were ro-
tated firmly and allowed to solidify at room temperature for
5 min. Prepared antibiotic disks (200 µg and 400 µg) were placed
on the surface of the agar medium. The discs injected with
DMSO only were used as a control. Plates were kept at 4°C for
1 h, then incubated at 30°C for 24–48 h. The inhibition zones were
measured with a millimetre ruler at the end of the incubation
period.
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